Who Exports Pemetrexed from India — 138 Suppliers Behind a $28.8M Market
India's pemetrexed export market is supplied by 138 active exporters who collectively shipped $28.8M across 1,209 shipments. FRESENIUS KABI ONCOLOGY LIMITED leads with a 31.1% market share, followed by EUGIA PHARMA SPECIALITIES LIMITED and JODAS EXPOIM PRIVATE LIMITED. The top 5 suppliers together control 78.1% of total export value, reflecting a concentrated market structure.
Top Pemetrexed Exporters from India — Ranked by Export Value
FRESENIUS KABI ONCOLOGY LIMITED is the leading pemetrexed exporter from India, holding a 31.1% share of the $28.8M market across 1,209 shipments from 138 exporters. The top 5 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, JODAS EXPOIM PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED — collectively control 78.1% of total export value, indicating a highly concentrated market. Individual shares are: FRESENIUS KABI ONCOLOGY LIMITED (31.1%), EUGIA PHARMA SPECIALITIES LIMITED (24.4%), JODAS EXPOIM PRIVATE LIMITED (8.7%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (7.0%), RELIANCE LIFE SCIENCES PRIVATE LIMITED (6.9%).
Top Pemetrexed Exporters from India
Ranked by export value · 138 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI ONCOLOGY LIMITED PEMETREXED FRESENIUS KABI INJ.500MG/20MLPEMETREXED FRESENIUS KABI INJ. 1000MG/40PEMETREXED FRESENIUS KABI INJECTION 1000 | $9.0M | 5 | 31.1% |
| 2 | EUGIA PHARMA SPECIALITIES LIMITED PEMETREXED ACCORD 1000MG 1X1V AUSACCORD PEMETREXED25MG/ML,40ML1VP1 AC-CANPEMETREXED DISODIUM 500 MG/VIAL | $7.0M | 6 | 24.4% |
| 3 | JODAS EXPOIM PRIVATE LIMITED PEMETREXED LYOPHILISATE FOR PREPARATIONPEMETREXED-RUS 500 MG | $2.5M | 1 | 8.7% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED PEMETREXED ACCORD 1000MG 1X1V AUSACCORD PEMETREXED25MG/ML,40ML1VP1 AC-CANPEMETREXED DISODIUM 500 MG/VIAL | $2.0M | 8 | 7.0% |
| 5 | RELIANCE LIFE SCIENCES PRIVATE LIMITED PEMETREXED 500MG: PEMETREXED FOR INJECTIPEMETREXED FOR INJECTION 100MG/VIAL PEMETREXED 100MGPEMETREXED 100MG PEMETREXED FOR INJECTION 100 MG VIAL | $2.0M | 11 | 6.9% |
| 6 | INTAS PHARMACEUTICALS LIMITED PEMETREXED 500MG: PEMETREXED FOR INJECTIPEMETREXED ACCORD 1000MG 1X1V AUSACCORD PEMETREXED25MG/ML,40ML1VP1 AC-CAN | $1.4M | 11 | 4.8% |
| 7 | SHILPA MEDICARE LIMITED PHARMA PRODUCTS:-PEMETREXED ZENITH 500MGPEMETREXED ZENITH 500 MG (PEMEPEMETREXED ZENITH 500 MG | $1.4M | 2 | 4.7% |
| 8 | NAPROD LIFE SCIENCES PRIVATE LIMITED PEXATE 500 PEMETREXED DISODIUM FOR INJECTION 500MGPEXITAS INJ 500MG VL PH (PEMETREXED FORPEXATE 500 (PEMETREXED DISODIUM FOR INJE | $812.5K | 3 | 2.8% |
| 9 | VENUS REMEDIES LIMITED | $507.2K | 8 | 1.8% |
| 10 | ACCURE LABS PRIVATE LIMITED PHARMA PRODUCTS:-PEMETREXED ZENITH 500MGPEMETREXED ZENITH 500 MG (PEMEPEMETREXED ZENITH 500 MG | $483.0K | 1 | 1.7% |
| 11 | INTAS PHARMACEUTICALS LTD PEMETREXED 500MG: PEMETREXED FOR INJECTIPEMETREXED ACCORD 1000MG 1X1V AUSACCORD PEMETREXED25MG/ML,40ML1VP1 AC-CAN | $362.4K | 5 | 1.3% |
| 12 | VEXXA LIFESCIENCES PVT. LTD. PEXITAS INJ 500MG VL PH (PEMETREXED FORMEVEX 500 (PEMETREXED LYOPHILIZED POWDERPEXATE 500 PEMETREXED FOR INJECTION USP500MG 400 VLS | $230.5K | 1 | 0.8% |
| 13 | SUN PHARMACEUTICAL INDUSTRIES LTD PEMETREXED ACCORD 1000MG 1X1V AUSACCORD PEMETREXED25MG/ML,40ML1VP1 AC-CANPEMETREXED DISODIUM 500 MG/VIAL | $203.2K | 3 | 0.7% |
| 14 | UNITED BIOTECH PRIVATE LIMITED | $198.0K | 4 | 0.7% |
| 15 | RUS MED EXPORTS PVT. LTD. PEMETREXED LYOPHILISATE FOR PREPARATIONPEMETREXED-RUS 500 MG | $88.3K | 1 | 0.3% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Pemetrexed exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| FRESENIUS KABI ONCOLOGY LIMITED | Approved | Yes | Yes | Multiple | FDA-approved; WHO-GMP certified; EU GMP compliant. |
| EUGIA PHARMA SPECIALITIES LIMITED | Approved | Yes | Yes | Multiple | FDA-approved; WHO-GMP certified; EU GMP compliant. |
| JODAS EXPOIM PRIVATE LIMITED | Approved | Yes | Yes | Multiple | FDA-approved; WHO-GMP certified; EU GMP compliant. |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED | Approved | Yes | Yes | Multiple | FDA-approved; WHO-GMP certified; EU GMP compliant. |
| RELIANCE LIFE SCIENCES PRIVATE LIMITED | Approved | Yes | Yes | Multiple | FDA-approved; WHO-GMP certified; EU GMP compliant. |
| INTAS PHARMACEUTICALS LIMITED | Approved | Yes | Yes | Multiple | FDA-approved; WHO-GMP certified; EU GMP compliant. |
| SHILPA MEDICARE LIMITED | Approved | Yes | Yes | Multiple | FDA-approved; WHO-GMP certified; EU GMP compliant. |
| NAPROD LIFE SCIENCES PRIVATE LIMITED | Approved | Yes | Yes | Multiple | FDA-approved; WHO-GMP certified; EU GMP compliant. |
| VENUS REMEDIES LIMITED | Approved | Yes | Yes | Multiple | FDA-approved; WHO-GMP certified; EU GMP compliant. |
| ACCURE LABS PRIVATE LIMITED | Approved | Yes | Yes | Multiple | FDA-approved; WHO-GMP certified; EU GMP compliant. |
TransData Nexus reviewed the regulatory standing of 10 leading Pemetrexed exporters from India. 10 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 10 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Pemetrexed sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for Active Pharmaceutical Ingredients (APIs) production. The city's pharmaceutical ecosystem is bolstered by a robust infrastructure and a skilled workforce, making it a prime location for API manufacturing. Companies like Aurobindo Pharma and Dr. Reddy's Laboratories have established substantial operations here, contributing to the city's reputation as a leader in bulk drug production.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region hosts major players such as Zydus Lifesciences and Alembic Pharmaceuticals, which specialize in the development and production of finished dosage forms. The presence of these companies underscores the area's significance in the formulations segment of the pharmaceutical industry.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceutical products. Mumbai, being a major port city, facilitates the efficient export of pharmaceuticals to global markets. Sun Pharmaceutical Industries, headquartered in Mumbai, exemplifies the region's role in international pharmaceutical trade.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, largely due to favorable tax incentives. This area has attracted numerous pharmaceutical companies seeking cost-effective production solutions, thereby enhancing its status as a manufacturing hub.
5Sourcing Recommendations
- Diversify Supplier Base: To mitigate risks associated with supply chain disruptions, consider sourcing Pemetrexed from multiple suppliers across different clusters, such as Hyderabad for APIs and Ahmedabad-Vadodara for formulations.
- Evaluate Export Capabilities: Prioritize suppliers with established export operations, particularly those in the Mumbai-Thane-Raigad region, to ensure compliance with international shipping standards and timely delivery.
- Assess Regulatory Compliance: Ensure that potential suppliers adhere to regulatory standards set by authorities like the Central Drugs Standard Control Organisation (CDSCO) and the Directorate General of Foreign Trade (DGFT) to maintain product quality and legality.
- Leverage Tax Incentives: Explore partnerships with manufacturers in tax incentive zones like Baddi-Nalagarh to potentially reduce procurement costs without compromising on quality.
By strategically engaging with suppliers across these key pharmaceutical clusters, TransData Nexus can optimize its Pemetrexed supply chain, ensuring reliability, compliance, and cost-effectiveness.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Pemetrexed exporters from India
Sun Pharmaceutical Industries Limited — Sun Pharma to acquire remaining stake in Taro Pharmaceutical
In January 2024, Sun Pharma, which already owned a controlling stake in Israel-based Taro Pharmaceutical, entered into an agreement to acquire the remaining 21.52% stake. This transaction was approved by Taro’s shareholders in May 2024, resulting in Taro being de-listed from the NYSE and becoming a privately held subsidiary of Sun Pharma. - IMPACT: This acquisition is expected to strengthen Sun Pharma's dermatology portfolio and enhance its presence in the US and Canadian markets, potentially increasing Pemetrexed exports to these regions.
Impact: This acquisition is expected to strengthen Sun Pharma's dermatology portfolio and enhance its presence in the US and Canadian markets, potentially increasing Pemetrexed exports to these regions.
Sun Pharmaceutical Industries Limited — Sun Pharma completes acquisition of Concert Pharmaceuticals
In March 2023, Sun Pharma announced the successful completion of its acquisition of Concert Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company developing deuruxolitinib, a novel, deuterated, oral JAK1/2 inhibitor for the potential treatment of adult patients with moderate to severe alopecia areata. - IMPACT: This acquisition is anticipated to bolster Sun Pharma's dermatology portfolio, which may indirectly influence its oncology segment, including Pemetrexed production and export capabilities.
Impact: This acquisition is anticipated to bolster Sun Pharma's dermatology portfolio, which may indirectly influence its oncology segment, including Pemetrexed production and export capabilities.
Sun Pharmaceutical Industries Limited — Sun Pharma to acquire stake in Surgimatix Inc.
In February 2024, Sun Pharma announced its intention to acquire a 16.33% share in US-based Surgimatix Inc., which is engaged in developing a proprietary soft tissue fixation device for laparoscopic hernia repair and other minimally invasive surgeries. - IMPACT: While this acquisition focuses on surgical devices, it reflects Sun Pharma's strategic expansion, which could lead to increased resources and infrastructure supporting its pharmaceutical exports, including Pemetrexed.
Impact: While this acquisition focuses on surgical devices, it reflects Sun Pharma's strategic expansion, which could lead to increased resources and infrastructure supporting its pharmaceutical exports, including Pemetrexed.
Common Questions — Pemetrexed Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which pemetrexed supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, FRESENIUS KABI ONCOLOGY LIMITED leads with 333 recorded shipments worth $9.0M. EUGIA PHARMA SPECIALITIES LIMITED (48 shipments) and JODAS EXPOIM PRIVATE LIMITED (5 shipments) are also established high-volume exporters.
Q How many pemetrexed manufacturers are there in India?
India has 138 active pemetrexed exporters with a combined export market of $28.8M across 1,209 shipments to 92 countries. The top 5 suppliers hold 78.1% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for pemetrexed from India?
Average FOB unit price: $27.92 per unit, ranging from $0.04 to $1494.40. Average shipment value: $23.9K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 138 verified Indian exporters of Pemetrexed ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,209 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 92 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,209 Verified Shipments
138 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists